{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:07:53Z","timestamp":1783386473029,"version":"3.54.6"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.physbeh.2022.113989","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T19:27:23Z","timestamp":1664911643000},"page":"113989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Vortioxetine treatment decreases cocaine-induced locomotor sensitization in rats"],"prefix":"10.1016","volume":"257","author":[{"given":"Susana","family":"Barbosa-M\u00e9ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Perez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1787-1657","authenticated-orcid":false,"given":"Alberto","family":"Salazar-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2022.113989_bib0001","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/09637214211026984","article-title":"The profound heterogeneity of substance use disorders: implications for treatment development","volume":"30","author":"Carroll","year":"2021","journal-title":"Curr. Dir. Psychol. Sci."},{"key":"10.1016\/j.physbeh.2022.113989_bib0002","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0740-5472(03)00165-X","article-title":"Web-based interventions for substance use disorders: a qualitative review","volume":"26","author":"Copeland","year":"2004","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.physbeh.2022.113989_bib0003","first-page":"112","article-title":"Substance misuse and substance use disorders: why do they matter in healthcare?","volume":"128","author":"McLellan","year":"2017","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"10.1016\/j.physbeh.2022.113989_bib0004","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jsat.2010.11.010","article-title":"A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients","volume":"40","author":"Winstanley","year":"2011","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.physbeh.2022.113989_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/WNF.0000000000000011","article-title":"Bupropion as an add-on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence","volume":"37","author":"Sepede","year":"2014","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0006","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2147\/DDDT.S257494","article-title":"Potential impact of the multi-target drug approach in the treatment of some complex diseases","volume":"14","author":"Makhoba","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.physbeh.2022.113989_bib0007","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fphar.2015.00205","article-title":"Multi-target pharmacology: possibilities and limitations of the \"skeleton key approach\" from a medicinal chemist perspective","volume":"6","author":"Talevi","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0008","doi-asserted-by":"crossref","first-page":"e40262","DOI":"10.1371\/journal.pone.0040262","article-title":"Multi-target drugs: the trend of drug research and development","volume":"7","author":"Lu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.physbeh.2022.113989_bib0009","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.111.189068","article-title":"Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder","volume":"340","author":"M\u00f8rk","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.physbeh.2022.113989_bib0010","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/jm101459g","article-title":"Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder","volume":"54","author":"Bang-Andersen","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.physbeh.2022.113989_bib0011","first-page":"900","article-title":"Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety","volume":"13","author":"Adell","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.physbeh.2022.113989_bib0012","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pharmthera.2014.07.001","article-title":"Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data","volume":"145","author":"Sanchez","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.physbeh.2022.113989_bib0013","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1017\/S1092852915000358","article-title":"Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): actions at serotonin receptors may enhance the downstream release of four pro-cognitive neurotransmitters","volume":"20","author":"Stahl","year":"2015","journal-title":"CNS Spectr"},{"key":"10.1016\/j.physbeh.2022.113989_bib0014","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.euroneuro.2012.04.006","article-title":"Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters\u2013a rat microdialysis and electrophysiology study","volume":"23","author":"Pehrson","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0015","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/0269881118788826","article-title":"Efficacy of vortioxetine on the physical symptoms of major depressive disorder","volume":"32","author":"Christensen","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0016","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jad.2017.11.081","article-title":"Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: a novel dual outcome measure in depressive disorders","volume":"227","author":"Christensen","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.physbeh.2022.113989_bib0017","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/13651501.2017.1397700","article-title":"Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study","volume":"23","author":"Wang","year":"2019","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.physbeh.2022.113989_bib0018","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1038\/s41598-021-88462-7","article-title":"Vortioxetine ameliorates anhedonic-like behaviour and promotes strategic cognitive performance in a rodent touchscreen task","volume":"11","author":"Martis","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.physbeh.2022.113989_bib0019","doi-asserted-by":"crossref","first-page":"217","DOI":"10.21307\/ane-2020-020","article-title":"Antistress and antidepressant properties of dapoxetine and vortioxetine","volume":"80","author":"Ratajczak","year":"2020","journal-title":"Acta Neurobiol. Exp. (Wars)."},{"key":"10.1016\/j.physbeh.2022.113989_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21307\/ane-2019-002","article-title":"Antidepressant and anxiolytic efficacy of single, chronic and concomitant use of vortioxetine, dapoxetine and fluoxetine in prenatally stressed rats","volume":"79","author":"Ratajczak","year":"2019","journal-title":"Acta Neurobiol. Exp. (Wars)."},{"key":"10.1016\/j.physbeh.2022.113989_bib0021","first-page":"2895","article-title":"Effects of vortioxetine on depression model rats and expression of BDNF and Trk B in hippocampus","volume":"20","author":"Sun","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.physbeh.2022.113989_bib0022","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.euroneuro.2013.07.001","article-title":"Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism","volume":"24","author":"du Jardin","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0023","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S109285292000173X","article-title":"Effect of vortioxetine in subjects with major depressive and alcohol use disorders: a 6-month retrospective analysis","volume":"27","author":"Di Nicola","year":"2022","journal-title":"CNS Spectr"},{"key":"10.1016\/j.physbeh.2022.113989_bib0024","series-title":"Mirtazapine: Multi-Target strategies For Treating Substance Use Disorder and Depression. The Neuroscience of Depression: Features, Diagnosis and Treatment","first-page":"401","author":"Barbosa-M\u00e9ndez","year":"2021"},{"key":"10.1016\/j.physbeh.2022.113989_bib0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pnpbp.2016.02.010","article-title":"Mirtazapine prevents induction and expression of cocaine-induced behavioral sensitization in rats","volume":"68","author":"Salazar-Ju\u00e1rez","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2022.113989_bib0026","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/00952990802183921","article-title":"Mirtazapine, a noradrenergic and specific serotonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague-Dawley rats","volume":"34","author":"Kang","year":"2008","journal-title":"Am. J. Drug Alcohol Abuse."},{"key":"10.1016\/j.physbeh.2022.113989_bib0027","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.biopsych.2010.09.032","article-title":"Mirtazapine alters cue-associated methamphetamine seeking in rats","volume":"69","author":"Graves","year":"2011","journal-title":"Biol. Psychiatry."},{"issue":"13","key":"10.1016\/j.physbeh.2022.113989_bib0028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2202-13-65","article-title":"SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in rats","volume":"14","author":"Graves","year":"2012","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.physbeh.2022.113989_bib0029","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2012.07.007","article-title":"The atypical antidepressant mirtazapine attenuates expression of morphine-induced place preference and motor sensitization","volume":"1472","author":"Graves","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.physbeh.2022.113989_bib0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.drugalcdep.2008.08.005","article-title":"Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference","volume":"99","author":"Herrold","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.physbeh.2022.113989_bib0031","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbr.2011.07.009","article-title":"Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats","volume":"225","author":"Voigt","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.physbeh.2022.113989_bib0032","first-page":"92","article-title":"Context-dependent effects of a single administration of mirtazapine on the expression of methamphetamine-induced conditioned place preference","volume":"13","author":"Voigt","year":"2012","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.physbeh.2022.113989_bib0033","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejphar.2017.06.028","article-title":"Mirtazapine attenuates the expression of nicotine-induced locomotor sensitization in rats","volume":"812","author":"Barbosa-M\u00e9ndez","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0034","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpsychires.2017.03.021","article-title":"Mirtazapine attenuates cocaine seeking in rats","volume":"92","author":"Barbosa-M\u00e9ndez","year":"2017","journal-title":"J. Psychiatry Res."},{"key":"10.1016\/j.physbeh.2022.113989_bib0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.psychres.2017.05.006","article-title":"Dose- and time-dependent effects of mirtazapine on the expression of cocaine-induced behavioral sensitization in rats","volume":"254","author":"Barbosa-M\u00e9ndez","year":"2017","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.physbeh.2022.113989_bib0036","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejphar.2017.12.033","article-title":"Mirtazapine impairs acquisition and reinstatement of cocaine-induced place preference in rats","volume":"820","author":"Barbosa-M\u00e9ndez","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0037","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1177\/0269881118764991","article-title":"Mirtazapine attenuates nicotine-seeking behavior in rats","volume":"32","author":"Barbosa-M\u00e9ndez","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0038","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1177\/0269881119840521","article-title":"Mirtazapine attenuates anxiety- and depression-like behaviors in rats during cocaine withdrawal","volume":"33","author":"Barbosa-M\u00e9ndez","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2020.104817","article-title":"Mirtazapine reduces the expression of cocaine-induced locomotor sensitization in male and female Wistar rats","volume":"125","author":"Barbosa-M\u00e9ndez","year":"2020","journal-title":"Horm. Behav."},{"key":"10.1016\/j.physbeh.2022.113989_bib0040","article-title":"Effect of mirtazapine on craving in cocaine depended patients","author":"Nanni-Alvarado","year":"2021","journal-title":"Int. J. Mental Health Addict"},{"key":"10.1016\/j.physbeh.2022.113989_bib0041","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00213-010-1996-3","article-title":"Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats","volume":"213","author":"Zayara","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2022.113989_bib0042","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00008877-199712000-00004","article-title":"Stimulation of serotonin (5-HT)1A receptors attenuates the locomotor, but not the discriminative, effects of amphetamine and cocaine in rats","volume":"8","author":"Przegali\u00f1ski","year":"1997","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0043","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fnins.2014.00448","article-title":"The 5-HT7 receptor as a potential target for treating drug and alcohol abuse","volume":"8","author":"Hauser","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.physbeh.2022.113989_bib0044","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1111\/acer.12482","article-title":"Association between HTR7 genetic polymorphisms and alcohol dependence, using the alcohol use disorders identification test (AUDIT)","volume":"38","author":"Kim","year":"2014","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.physbeh.2022.113989_bib0045","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1517\/14740338.2015.1046836","article-title":"Vortioxetine: a review of efficacy, safety, and tolerability with a focus on cognitive symptoms in major depressive disorder","volume":"14","author":"Al-Sukhni","year":"2015","journal-title":"Expert. Opin. Drug Saf."},{"key":"10.1016\/j.physbeh.2022.113989_bib0046","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2147\/NDT.S41387","article-title":"Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder","volume":"10","author":"Alvarez","year":"2014","journal-title":"Neuropsychiatry Dis. Treat."},{"key":"10.1016\/j.physbeh.2022.113989_bib0047","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pnpbp.2017.07.008","article-title":"Effects of vortioxetine on biomarkers associated with glutamatergic activity in an SSRI insensitive model of depression in female rats","volume":"82","author":"Hlavacova","year":"2018","journal-title":"Prog. Neuropsychopharmacol Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2022.113989_bib0048","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12868-017-0376-x","article-title":"Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents","volume":"18","author":"Waller","year":"2017","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.physbeh.2022.113989_bib0049","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/jnc.14043","article-title":"Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior","volume":"142","author":"Eskelund","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.physbeh.2022.113989_bib0050","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1007\/s00213-016-4407-6","article-title":"Effects of sertraline, duloxetine, vortioxetine, and idazoxan in the rataffective bias test","volume":"233","author":"Refsgaard","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2022.113989_bib0051","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s00213-016-4327-5","article-title":"Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression","volume":"233","author":"du Jardin","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2022.113989_bib0052","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2016.05.029","article-title":"A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex","volume":"786","author":"du Jardin","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0053","doi-asserted-by":"crossref","first-page":"9063","DOI":"10.1038\/s41598-018-27352-x","article-title":"Chronic infection with Mycobacterium lepraemurium induces alterations in the hippocampus associated with memory loss","volume":"8","author":"Becerril-Villanueva","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.physbeh.2022.113989_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172932","article-title":"Administration of low doses of the 5-HT1Areceptor agonist 8-OH-DPAT attenuates the discriminative signal of amphetamine in the conditioned taste aversion procedure","volume":"193","author":"Sandoval-S\u00e1nchez","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2022.113989_bib0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0166-4328(01)00383-7","article-title":"5-HT1A agonist\/antagonist modification of cocaine stimulant effects: implications for cocaine mechanisms","volume":"132","author":"Carey","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2022.113989_bib0056","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0091-3057(01)00750-X","article-title":"8-OHDPAT effects upon cocaine unconditioned and conditioned behaviors: a role for drug stimulus effects","volume":"72","author":"Carey","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2022.113989_bib0057","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/hipo.10209","article-title":"Hippocampus 5-HT(1A)-receptors attenuate cocaine-induced hyperlocomotion and the increase in hippocampal but not nucleus accumbens 5-HT","volume":"14","author":"M\u00fcller","year":"2004","journal-title":"Hippocampus"},{"key":"10.1016\/j.physbeh.2022.113989_bib0058","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0028-3908(03)00046-7","article-title":"Serotonin1A-receptor agonism attenuates the cocaine-induced increase in serotonin levels in the hippocampus and nucleus accumbens but potentiates hyperlocomotion: an in vivo microdialysis study","volume":"44","author":"M\u00fcller","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2022.113989_bib0059","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/02698811211019279","article-title":"5-HT1Breceptor agonist attenuates cocaine self-administration after protracted abstinence and relapse in rats","volume":"35","author":"Scott","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0060","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/ijnp\/pyx025","article-title":"Preclinical evidence that 5-HT1B receptor agonists show promise as medications for psychostimulant use disorders","volume":"20","author":"Garcia","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0061","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/cn400155t","article-title":"Pharmacological evidence for an abstinence-induced switch in 5-HT1B receptor modulation of cocaine self-administration and cocaine-seeking behavior","volume":"5","author":"Pentkowski","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.physbeh.2022.113989_bib0062","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0924-977X(03)00106-8","article-title":"Effects of 5-HT1B receptor ligands microinjected into the ventral tegmental area on the locomotor and sensitizating effects of cocaine in rats","volume":"14","author":"Przegali\u0144ski","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0063","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00008877-200104000-00004","article-title":"Effect of serotonin (5-HT)1B receptor ligands on cocaine sensitization in rats","volume":"12","author":"Przegali\u00f1ski","year":"2001","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0064","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1734-1140(13)71062-4","article-title":"Effects of serotonin (5-HT)1B receptor ligands on amphetamine-seeking behavior in rats","volume":"65","author":"Miszkiel","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.physbeh.2022.113989_bib0065","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1471-4159.2006.04163.x","article-title":"Biphasic alterations in serotonin-1B (5-HT1B) receptor function during abstinence from extended cocaine self-administration","volume":"99","author":"O'Dell","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.physbeh.2022.113989_bib0066","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pbb.2004.12.001","article-title":"Stimulation of 5-HT1B receptors decreases cocaine- and sucrose-seeking behavior","volume":"80","author":"Acosta","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2022.113989_bib0067","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0091-3057(02)00985-1","article-title":"The 5-HT3 antagonist Y-25130 blocks cocaine-induced lowering of ICSS reward thresholds in the rat","volume":"74","author":"Kelley","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2022.113989_bib0068","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00023210-200923050-00006","article-title":"Mirtazapine: a review of its use in major depression and other psychiatric disorders","volume":"23","author":"Croom","year":"2009","journal-title":"CNS Drugs"},{"issue":"Suppl 4","key":"10.1016\/j.physbeh.2022.113989_bib0069","first-page":"19","article-title":"The pharmacologic profile of mirtazapine","volume":"57","author":"de Boer","year":"1996","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.physbeh.2022.113989_bib0070","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1124\/mol.107.041574","article-title":"Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction","volume":"73","author":"Chanrion","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0071","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.brainresbull.2004.02.007","article-title":"Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"63","author":"Nakayama","year":"2004","journal-title":"Brain Res. Bull"},{"key":"10.1016\/j.physbeh.2022.113989_bib0072","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.3390\/molecules26082398","article-title":"Serotonergic neurotransmission system modulator, vortioxetine, and dopaminergic D2\/D3receptor agonist, ropinirole, attenuate fibromyalgia-like symptoms in mice","volume":"26","author":"Sa\u0142at","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.physbeh.2022.113989_bib0073","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3389\/fphar.2018.01024","article-title":"Vortioxetine differentially modulates MK-801-induced changes in visual signal detection task performance and locomotor activity","volume":"9","author":"Hillhouse","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0074","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0306-4522(02)00272-5","article-title":"Withdrawal duration differentially affects c-fos expression in the medial prefrontal cortex and discrete sub-regions of the nucleus accumbens in cocaine-sensitized rats","volume":"114","author":"Todtenkopf","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2022.113989_bib0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130000493","article-title":"Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies","volume":"151","author":"Vanderschuren","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.physbeh.2022.113989_bib0076","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increaseynaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.physbeh.2022.113989_bib0077","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1523\/JNEUROSCI.13-01-00266.1993","article-title":"Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals","volume":"13","author":"Kalivas","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2022.113989_bib0078","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1523\/JNEUROSCI.13-01-00276.1993","article-title":"Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya","volume":"13","author":"Kalivas","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2022.113989_bib0079","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0028-3908(02)00381-7","article-title":"Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens","volume":"44","author":"Bubar","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2022.113989_bib0080","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-2999(91)90456-Z","article-title":"Effect of cocaine and 5-HT3 receptor antagonists on 5-HT-induced [3H] dopamine release from rat striatal synaptosomes","volume":"199","author":"Yi","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2022.113989_bib0081","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/syn.20323","article-title":"Modification of cocaine-induced behavioral and neurochemical effects by serotonin1A receptor agonist\/antagonist in mice","volume":"60","author":"Nakamura","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.physbeh.2022.113989_bib0082","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00213-011-2447-5","article-title":"Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex","volume":"219","author":"Devoto","year":"2012","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938422002955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938422002955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:22:35Z","timestamp":1758478955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938422002955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":82,"alternative-id":["S0031938422002955"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2022.113989","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vortioxetine treatment decreases cocaine-induced locomotor sensitization in rats","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2022.113989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113989"}}